Finance

Beta
Lists
VKTX:NASDAQ
Viking Therapeutics Inc
$36.99
-2.32%
(-0.88) 1D
$36.91
-0.21% (-0.078)
After hours
Closed: Jun 25, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VKTX...
Open
$38.00
High
$39.45
Low
$36.84
Mkt. cap
4.29B
Avg. vol.
2.28M
Volume
4.35M
52-wk high
$43.15
52-wk low
$22.96
EPS
-$4.15
Beta
0.69
Shares outstanding
116.11M
No. of employees
59
Open
$38.00
High
$39.45
Low
$36.84
Mkt. cap
4.29B
Avg. vol.
2.28M
Volume
4.35M
52-wk high
$43.15
52-wk low
$22.96
EPS
-$4.15
Beta
0.69
Shares outstanding
116.11M
No. of employees
59
News stories
From sources across the web
About Viking Therapeutics Inc
CEOBrian Lian
Employees59
Founded2012
Headquarters-
SectorBiotechnology
Websitevikingtherapeutics.com
Analyst ratings
Based on 13 analysts giving stock ratings to VKTX in the past 3 months
Strong buy
Buy
13
Hold
0
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for VKTX in the last 3 months.
Highest
Current $36.99
$125.00 (+237.93%)
Average
$92.91 (+151.18%)
Lowest
$70.00 (+89.24%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
$70.00
+89.2%
06/24/2026
William Wood
B. Riley Securities
Buy
Reiterated
$85.00
+129.8%
06/25/2026
Michael Ulz
Morgan Stanley
Buy
Maintained
$95.00
+156.8%
06/24/2026
Ryan Deschner
Raymond James
Buy
Maintained
-
-
06/24/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$102.00
+175.8%
06/24/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
06/09/2026
Daniel Brims
Lake Street
Buy
Initiated
$89.00
+140.6%
05/28/2026
Joon Lee
Truist Financial
Buy
Initiated
$83.00
+124.4%
05/27/2026
Gregory Renza
Truist Financial
Buy
Initiated
$83.00
+124.4%
05/27/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
$107.00
+189.3%
05/04/2026
Annabel Samimy
Stifel Nicolaus
Buy
Maintained
$95.00
+156.8%
04/30/2026
Jeet Mukherjee
BTIG
Buy
Reiterated
$125.00
+237.9%
05/01/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$100.00
+170.3%
04/30/2026
Biren Amin
Piper Sandler
Buy
Maintained
$71.00
+91.9%
04/30/2026
Roger Song
Jefferies
Buy
Maintained
$101.00
+173%
02/12/2026
Unknown Analyst
B. Riley Securities
Buy
Initiated
$85.00
+129.8%
02/12/2026
Hardik Parikh
J.P. Morgan
Buy
Maintained
$75.00
+102.8%
02/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
60.15M
89.95M
153.46M
150.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.42M
8.61M
11.28M
13.98M
Operating expense
74.57M
98.56M
164.74M
164.12M
Total operating expenses
74.57M
98.56M
164.74M
164.12M
Operating income
-74.57M
-98.56M
-164.74M
-164.12M
Other non operating income
-
-
-
-
EBT including unusual items
-65.56M
-90.79M
-157.66M
-158.32M
EBT excluding unusual items
-65.56M
-90.80M
-157.70M
-158.32M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-65.56M
-90.79M
-157.66M
-158.32M
Net profit margin
-
-
-
-
Earnings per share
-0.58
-0.81
-1.38
-1.37
Interest and investment income
9.03M
7.77M
7.04M
5.80M
Interest expense
-24.00K
-8.00K
-
-
Net interest expenses
9.01M
7.76M
7.04M
5.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of VKTX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer